Popular Boards

Zheng-Bin Liao, Zicheng Hu, Gui‐Hua Zeng | The Journal of Prevention of Alzheimer s Disease | (2026)

Key Takeaways

Plain English Takeaway

Taking omega-3 supplements may actually speed up memory and thinking problems in older adults, instead of helping to slow them down.

Study Aim

The study set out to determine whether omega-3 fatty acid supplements help slow or speed up memory and thinking decline in older adults. The researchers also wanted to find out if any changes were linked to the main brain changes seen in Alzheimer's disease, such as amyloid plaques, tau tangles, or loss of brain tissue. Simply put: The study wanted to see if omega-3 supplements help or hurt memory in older people, and why.

Study Design

This was a long-term observational study using data from the Alzheimer's Disease Neuroimaging Initiative (ADNI). The researchers compared older adults who took omega-3 supplements (like fish oil) with those who did not. They matched participants by age, sex, genetic risk for Alzheimer's (APOE ε4 status), and diagnosis. The study followed 273 omega-3 users and 546 non-users for a median of 5 years. Memory and thinking were measured with standard tests, and brain scans tracked changes in amyloid, tau, brain volume, and brain metabolism. Simply put: The study followed two groups of older adults for several years to see how taking omega-3 supplements affected their memory and brain health.

Findings

The research demonstrates that older adults who took omega-3 supplements experienced faster memory and thinking decline compared to those who did not. This faster decline was not linked to the usual Alzheimer's disease brain changes, such as amyloid buildup, tau tangles, or brain shrinkage. Instead, the study reveals that lower brain glucose metabolism (a sign of weaker connections between brain cells) explained much of the decline. The authors argue that omega-3 supplements may harm brain cell function in some older adults, challenging the common belief that these supplements are always helpful. They recommend caution in using omega-3 supplements for cognitive protection and call for more research to understand who might benefit or be harmed. Simply put: The study found that omega-3 supplements might make memory problems worse in older adults, possibly by hurting how brain cells work together.

Abstract

BACKGROUND: While omega-3 fatty acid supplementation is widely used for cognitive protection, its efficacy remains controversial, and its impact on core Alzheimer's disease (AD) pathologies in humans is not well-established. METHODS: This longitudinal study utilized data from the Alzheimer's Disease Neuroimaging Initiative (ADNI). We employed linear mixed-effects models to assess the association between omega-3 supplementation and longitudinal cognitive decline, and mediation analyses to examine whether this relationship was mediated by core AD pathologies (Aβ-PET, tau-PET, T1-MRI, FDG-PET). RESULTS: Omega-3 supplementation was associated with significantly accelerated cognitive decline, as evidenced by a faster decrease in MMSE scores (β = -0.266, p < 0.001) and a faster increase in both ADAS-Cog13 (β = 0.823, p < 0.001) and CDR-SB scores (β = 0.205, p < 0.001). This association was not mediated by Aβ deposition, tau pathology, or gray matter atrophy. Instead, longitudinal FDG hypometabolism within AD-vulnerable regions served as a significant mediating pathway, accounting for 30.8%, 40.8%, and 19.0% of the total effect on the decline in MMSE, ADAS-Cog13, and CDR-SB, respectively. CONCLUSIONS: Omega-3 supplementation may be associated with accelerated cognitive decline in older adults, potentially through adverse effects on cerebral synaptic function rather than classical AD proteinopathies. These findings challenge the prevailing view of omega-3 as uniformly beneficial and highlight the need for a cautious reassessment of its widespread use for cognitive protection.

Referenced In

N-3 Fatty Acids and Cognitive Decline: New Evidence and Old Questions

A new study published last week in the American Journal of Clinical Nutrition purported to find benefits of a peptide and fatty-acid supplement on cognitive function in older adults, stirring up a long-running debate.

Does eating or supplementing with n-3 polyunsaturated fatty acids (PUFAs) help to slow cognitive decline? Could they help prevent or treat conditions like Alzheimer’s?

New Study Suggests Fish Hydrolysate Improves Episodic and Working Memory

The study randomized 53 healthy older adults to receive either fish hydrolysate or a placebo, and tracked their cognitive performance for three months.

Fish “hydrolysate” is a supplement containing low molecular weight peptides and n-3 PUFAs. Two of the study’s authors worked for a company manufacturing such products.

They found:

  • People taking the supplement performed better on a test of visuospatial learning and episodic memory.  

  • The supplementation group performed better on some measures of working memory, with no differences on others.

The authors mention that larger-scale trials often find no impact of PUFAs on global cognition or in specific areas, but that results are inconsistent. However, with its small sample size, this study doesn’t clear much up.

Do n-3 PUFAs Have Cognitive Benefits?

There are other suggestions that PUFAs may have benefits. In fact, two systematic reviews and meta-analyses found a benefit for mild cognitive impairment.

One 2024 review included 12 studies with 1,124 participants in total. They found evidence of a benefit relative to placebo on global cognition, but noted no differences in language fluency or executive functions. The authors also pointed out that more evidence is needed.

Another review from 2019 looked at 7 randomized controlled trials with 434 participants in total, and found improvements in cognition among elderly adults with mild cognitive impairment. In this (and the previous) review, the authors noted that results varied substantially between studies.

A More Complicated Picture

Evidence for specific conditions like Alzheimer’s is less convincing. For example, one longitudinal study looking at 819 people with Alzheimer’s disease found that omega-3 PUFA supplementation actually accelerated cognitive decline.

The authors of this study point to another review which noted improvements at lower dosages but issues at higher dosages.

Overall, while n-3 fatty acids may help mild cognitive impairments at lower doses, the evidence is shakier for more serious issues and higher dosages.

0